K. Reszka

发表

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study.

P. Krawczyk, J. Milanowski, J. Szumiło, 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021, Scientific Reports.

Cytology Smears as Diagnostic Material for EGFR Gene Testing in Non-small Cell Lung Cancer

P. Krawczyk, J. Milanowski, J. Pankowski, 2015, Tumori.

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Oncology letters.

Analysis of ROS1 gene rearrangement incidence among NSCLC patients with fluorescent in situ hybridization technique

P. Krawczyk, J. Milanowski, R. Ramlau, 2020 .

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma

P. Krawczyk, J. Milanowski, R. Ramlau, 2021, Oncology letters.

The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression — focus on intestinal microbiome

P. Krawczyk, J. Milanowski, I. Chmielewska, 2020 .

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients.

P. Krawczyk, J. Milanowski, J. Szumiło, 2019, Cancer genetics.

Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma

M. Szczyrek, P. Krawczyk, J. Milanowski, 2017 .

Reply to the letter to the editor ‘ Prevalence of rare EGFR mutations in non-small cell lung cancer: a multicenter study on 3856 Polish Caucasian patients ’

P. Krawczyk, J. Milanowski, R. Ramlau, 2016 .

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases

P. Krawczyk, J. Milanowski, J. Jassem, 2022, JTO clinical and research reports.

[Influence of animal breeding manner on the occurence of internal parasites].

K. Reszka, K. Romaniuk, Ewa Lasota, 2004, Wiadomosci parazytologiczne.

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

M. Szczyrek, P. Krawczyk, J. Milanowski, 2021, Frontiers in Oncology.

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

P. Krawczyk, J. Milanowski, J. Szumiło, 2017, Oncotarget.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer

P. Krawczyk, J. Milanowski, R. Ramlau, 2021, Archives of medical science : AMS.

Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2018, Journal of thoracic disease.

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Balkan Journal of Medical Genetics : BJMG.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

P. Krawczyk, R. Ramlau, A. Szczesna, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival analysis of advanced lung cancer patients undergoing personalised treatment or chemotherapy in a real clinic

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021 .